Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial
…, SH Belle, RH Neiberg, SK Pierson… - JAMA …, 2015 - jamanetwork.com
Importance Questions remain about the role and durability of bariatric surgery for type 2
diabetes mellitus (T2DM). Objective To compare the remission of T2DM following surgical and …
diabetes mellitus (T2DM). Objective To compare the remission of T2DM following surgical and …
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
…, S Schey, M Streetly, SK Pierson… - Blood, The Journal …, 2018 - ashpublications.org
Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric (MCD) …
characteristic histopathological features. CD can present with unicentric or multicentric (MCD) …
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease
…, MJ Lechowicz, S Chandrakasan, SK Pierson… - Blood …, 2020 - ashpublications.org
Castleman disease (CD) includes a group of rare and heterogeneous disorders with
characteristic lymph node histopathological abnormalities. CD can occur in a single lymph node …
characteristic lymph node histopathological abnormalities. CD can occur in a single lymph node …
[HTML][HTML] Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease
…, AS Japp, HL Partridge, SK Pierson… - The Journal of …, 2019 - Am Soc Clin Investig
Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic illness of systemic
inflammation and organ dysfunction, with unknown etiology. Although therapies targeting IL-6 …
inflammation and organ dysfunction, with unknown etiology. Although therapies targeting IL-6 …
Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of …
…, DC Fajgenbaum, SK Pierson… - American Journal of …, 2021 - Wiley Online Library
Thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly
(TAFRO) syndrome is a heterogeneous entity manifesting with a constellation of symptoms …
(TAFRO) syndrome is a heterogeneous entity manifesting with a constellation of symptoms …
Urinary incontinence before and after bariatric surgery
…, S Khandelwal, JR Pender, SK Pierson… - JAMA internal …, 2015 - jamanetwork.com
Importance Among women and men with severe obesity, evidence for improvement in urinary
incontinence beyond the first year after bariatric surgery–induced weight loss is lacking. …
incontinence beyond the first year after bariatric surgery–induced weight loss is lacking. …
[HTML][HTML] Treatments administered to the first 9152 reported cases of COVID-19: a systematic review
…, R Rasheed, E Napier, D Mackay, SK Pierson - Infectious diseases and …, 2020 - Springer
The emergence of SARS-CoV-2/2019 novel coronavirus (COVID-19) has created a global
pandemic with no approved treatments or vaccines. Many treatments have already been …
pandemic with no approved treatments or vaccines. Many treatments have already been …
Plasma proteomics identifies a 'chemokine storm'in idiopathic multicentric Castleman disease
SK Pierson, AJ Stonestrom, D Shilling… - American journal of …, 2018 - Wiley Online Library
Human Herpesvirus‐8 (HHV‐8)‐negative/idiopathic multicentric Castleman disease (iMCD)
is a poorly understood disease involving polyclonal lymphoproliferation with dysmorphic …
is a poorly understood disease involving polyclonal lymphoproliferation with dysmorphic …
Increased mTOR activation in idiopathic multicentric Castleman disease
…, J Khor, SAT Parente, SK Pierson… - Blood, The Journal …, 2020 - ashpublications.org
Idiopathic multicentric Castleman disease (iMCD) is a rare and poorly understood hematologic
disorder characterized by lymphadenopathy, systemic inflammation, cytopenias, and life-…
disorder characterized by lymphadenopathy, systemic inflammation, cytopenias, and life-…
[HTML][HTML] Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease
…, RF Rasheed, M Okumura, D Arenas, SK Pierson… - JCI insight, 2020 - ncbi.nlm.nih.gov
The TAFRO clinical subtype of idiopathic multicentric Castleman disease (iMCD-TAFRO) is
a rare hematologic illness involving episodic disease flares of thrombocytopenia, anasarca, …
a rare hematologic illness involving episodic disease flares of thrombocytopenia, anasarca, …